BioXcel Therapeutics
BTAI
#9513
Rank
ยฃ20.65 M
Marketcap
ยฃ0.51
Share price
2.37%
Change (1 day)
-86.91%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of June 2024 : ยฃ43.2 Million

According to BioXcel Therapeutics's latest financial reports the company has ยฃ43.2 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31ยฃ0.16 B-7.22%
2021-12-31ยฃ0.17 B10.38%
2020-12-31ยฃ0.15 B532.29%
2019-12-31ยฃ24.72 M-26.26%
2018-12-31ยฃ33.53 M5009.32%
2017-12-31ยฃ0.65 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.21 B 408.98%๐Ÿ‡บ๐Ÿ‡ธ USA